EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

MDM2 suppresses c-Myc synthesis by binding to the 5’ mRNA translation regulatory sequence

Justine Habault iD, Norman Salomao, Lixiao Wang, Laurence Malbert-Colas iD, Chrysoula Daskalogianni iD, Sivakumar Vadivel Gnanasundram iD, Mitesh Dongre, Marzia Spagnardi, Lucia Martinkova iD, Sa Chen iD, Lenka Hernychová, Lucas Robidas und 7 weitere

Proceedings of the National Academy of Sciences · 30.06.2026 · 123 (26)

DOI: 10.1073/pnas.2611131123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.06.2026. Verfasst von Justine Habault und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Recherche Saint Louis, Unité Mixte de Recherches 1342, Université Paris Cité, Hôpital St. Louis, Paris 75010, France. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Proto-Oncogene Proteins c-myc, RNA, Messenger, Protein Biosynthesis. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancerforskningsfonden i Norrland (Cancerforskningsfonden Norrland), Cancerfonden (Swedish Cancer Society), Vetenskapsrådet (VR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The p53 tumor suppressor and the c-Myc oncogene are among the most frequently deregulated genes in human cancers, yet the molecular cross talk between these pathways remains poorly understood. MDM2 is a key negative regulator of p53 and a target for emerging cancer therapies designed to activate p53. Likewise, targeting c-Myc is a long-standing but challenging goal in cancer therapy. Here, we report that the small MDM2-binding drug Milademetan promotes an interaction between MDM2 and the 5’ untranslated region of the c-Myc mRNA, causing a suppression of c-Myc mRNA translation without affecting c-Myc RNA levels. The interaction also occurs under nonproliferative conditions in the absence of drug. Milademetan-mediated c-Myc depletion is accompanied by the induction of apoptosis and suppression of cell proliferation and prevents tumor growth, independently of p53 status. These findings reveal an unexpected mechanism by which MDM2 coordinates two of the most frequently altered pathways in cancer and provide a rationale for targeting c-Myc-driven tumors, including those lacking functional p53, through MDM2 modulators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mdm2Proto-Oncogene Proteins c-mycRNA, MessengerProtein BiosynthesisHumansAnimals5' Untranslated RegionsTumor Suppressor Protein p53Cell ProliferationCell Line, TumorMiceApoptosisGene Expression Regulation, NeoplasticProtein Binding

Stichwörter der Autor:innen

MDM2-RNA interactionc-MYCp53translation controltumor heterogeneity

Substanzen

Proto-Oncogene Proteins c-mdm2Proto-Oncogene Proteins c-myc5' Untranslated RegionsRNA, MessengerTumor Suppressor Protein p53MDM2 protein, human

Autor:innen und Institutionen

  • Institut de Recherche Saint Louis, Unité Mixte de Recherches 1342, Université Paris Cité, Hôpital St. Louis, Paris 75010, France.
  • Department of Medical Biosciences, Umeå University, Umeå 901 85, Sweden.
  • Department of Biological Sciences and Engineering, Indian Institute of Technology Palakkad, Palakkad 678 623, India.
  • Department of Diagnostics and Intervention, Umeå University, Umeå 901 85, Sweden.
  • Department of Urology, New York University Grossman School of Medicine, New York, NY 10016.
  • Research Center for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno 65653, Czech Republic.

ORCID-Profile: Justine Habault, Laurence Malbert-Colas, Chrysoula Daskalogianni, Sivakumar Vadivel Gnanasundram, Lucia Martinkova, Sa Chen, Ondřej Bonczek, Daniel Öhlund, Michael J Garabedian, Borek Vojtesek, Robin Fahraeus

Förderung

  • Cancerforskningsfonden i Norrland (Cancerforskningsfonden Norrland)
  • Cancerfonden (Swedish Cancer Society)
  • Vetenskapsrådet (VR)
  • Agence Nationale de la Recherche (ANR)
  • Czech Science Foundation

Zitieren

APA

Habault, J., Salomao, N., Wang, L., Malbert-Colas, L., Daskalogianni, C., Vadivel Gnanasundram, S., Dongre, M., Spagnardi, M., Martinkova, L., Chen, S., Hernychová, L., Robidas, L., Kucera, J., Bonczek, O., Öhlund, D., Garabedian, M. J., Logan, S. K., Vojtesek, B., & Fahraeus, R. (2026). MDM2 suppresses c-Myc synthesis by binding to the 5’ mRNA translation regulatory sequence. Proceedings of the National Academy of Sciences, 123(26). https://doi.org/10.1073/pnas.2611131123

Vancouver

Habault J, Salomao N, Wang L, Malbert-Colas L, Daskalogianni C, Vadivel Gnanasundram S, et al. MDM2 suppresses c-Myc synthesis by binding to the 5’ mRNA translation regulatory sequence. Proceedings of the National Academy of Sciences. 2026;123(26). doi:10.1073/pnas.2611131123

BibTeX
@article{Habault2026,
  author = {Habault, Justine and Salomao, Norman and Wang, Lixiao and Malbert-Colas, Laurence and Daskalogianni, Chrysoula and Vadivel Gnanasundram, Sivakumar and Dongre, Mitesh and Spagnardi, Marzia and Martinkova, Lucia and Chen, Sa and Hernychová, Lenka and Robidas, Lucas and Kucera, Josef and Bonczek, Ondřej and Öhlund, Daniel and Garabedian, Michael J and Logan, Susan K and Vojtesek, Borek and Fahraeus, Robin},
  title = {MDM2 suppresses c-Myc synthesis by binding to the 5’ mRNA translation regulatory sequence},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {26},
  doi = {10.1073/pnas.2611131123}
}
Kostenlos starten →